- Release Date: 03/06/21 08:49
- Summary: Upgraded FY21 earnings guidance by 10 to 15%
- Price Sensitive: Yes
- Download Document 358.88KB
- Forums
- ASX - By Stock
- ACL
- Ann: Upgraded FY21 earnings guidance by 10 to 15%
ACL
australian clinical labs limited
Add to My Watchlist
3.05%
!
$2.54

Ann: Upgraded FY21 earnings guidance by 10 to 15%
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.54 |
Change
-0.080(3.05%) |
Mkt cap ! $498.8M |
Open | High | Low | Value | Volume |
$2.61 | $2.63 | $2.52 | $2.003M | 785.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 395 | $2.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.56 | 4907 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 395 | 2.530 |
4 | 14425 | 2.520 |
4 | 6909 | 2.510 |
12 | 17700 | 2.500 |
6 | 23732 | 2.490 |
Price($) | Vol. | No. |
---|---|---|
2.560 | 4907 | 1 |
2.630 | 11000 | 2 |
2.660 | 30000 | 1 |
2.680 | 5428 | 1 |
2.700 | 12127 | 3 |
Last trade - 16.10pm 09/09/2025 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |